|
1
|
Berndt N, Bolman C, Froelicher ES, Mudde
A, Candel M, de Vries H and Lechner L: Effectiveness of a telephone
delivered and a face-to-face delivered counseling intervention for
smoking cessation in patients with coronary heart disease: A
6-month follow-up. J Behav Med. 37:709–724. 2014.PubMed/NCBI
|
|
2
|
Moser DK, McKinley S, Riegel B, Doering
LV, Meischke H, Pelter M, Davidson P, Baker H and Dracup K: The
impact on anxiety and perceived control of a short one-on-one
nursing intervention designed to decrease treatment seeking delay
in people with coronary heart disease. Eur J Cardiovasc Nurs.
11:160–167. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grunwald V, Karakiewicz PI, Bavbek SE,
Miller K, Machiels JP, Lee SH, Larkin J, Bono P, Rha SY, Castellano
D, et al: An international expanded-access programme of everolimus:
Addressing safety and efficacy in patients with metastatic renal
cell carcinoma who progress after initial vascular endothelial
growth factor receptor-tyrosine kinase inhibitor therapy. Eur J
Cancer. 48:324–332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Derosa G, Bonaventura A, Bianchi L, Romano
D, D'Angelo A, Fogari E and Maffioli P: A randomized,
placebo-controlled study on the effects of a nutraceutical
combination of red yeast rice, silybum marianum and octasonol on
lipid profile, endothelial and inflammatory parameters. J Biol
Regul Homeost Agents. 28:317–324. 2014.PubMed/NCBI
|
|
5
|
Kuravi SJ, McGettrick HM, Satchell SC,
Saleem MA, Harper L, Williams JM, Rainger GE and Savage CO:
Podocytes regulate neutrophil recruitment by glomerular endothelial
cells via IL-6-mediated crosstalk. J Immunol. 193:234–243. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen G, Qiu H, Ke S, Hu S, Yu S and Zou S:
The fibroblast growth factor receptor 2-mediated extracellular
signal-regulated kinase 1/2 signaling pathway plays is important in
regulating excision repair cross-complementary gene 1 expression in
hepatocellular carcinoma. Biomed Rep. 1:604–608. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haga S, Tsuchiya H, Hirai T, Hamano T,
Mimori A and Ishizaka Y: A novel ACE2 activator reduces
monocrotaline-induced pulmonary hypertension by suppressing the
JAK/STAT and TGF-β cascades with restored caveolin-1 expression.
Exp Lung Res. 41:21–31. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han JK, Kim HL, Jeon KH, Choi YE, Lee HS,
Kwon YW, Jang JJ, Cho HJ, Kang HJ, Oh BH, et al: Peroxisome
proliferator-activated receptor-δ activates endothelial progenitor
cells to induce angio-myogenesis through matrix
metallo-proteinase-9-mediated insulin-like growth factor-1
paracrine networks. Eur Heart J. 34:1755–1765. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ellis HP and Kurian KM: Biological
rationale for the use of PPARγ agonists in glioblastoma. Front
Oncol. 4:522014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aydoğan HY, Küçükhüseyin O, Tekeli A and
Isbir T: Associations of receptor for advanced glycation end
products-374 T/A and Gly82 Ser and peroxisome
proliferator-activated receptor gamma Pro12Ala polymorphisms in
Turkish coronary artery disease patients. Genet Test Mol
Biomarkers. 16:134–137. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang TH and Roufogalis BD: Healing the
diabetic heart: Modulation of cardiometabolic syndrome through
peroxisome proliferator activated receptors (PPARs). Curr Mol
Pharmacol. 5:241–247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Z, Wu Z, Zhu X, Hui X, Pan J and Xu
Y: Hydroxy-safflor yellow A inhibits neuroinflammation mediated by
Aβ(1)(−)(4)(2) in BV-2 cells. Neurosci Lett. 562:39–44. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou MX, Fu JH, Zhang Q and Wang JQ:
Effect of hydroxy safflower yellow A on myocardial apoptosis after
acute myocardial infarction in rats. Genet Mol Res. 14:3133–3141.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kaysen GA, Levin NW, Mitch WE, Chapman AL,
Kubala L and Eiserich JP: Evidence that C-reactive protein or IL-6
are not surrogates for all inflammatory cardiovascular risk factors
in hemodialysis patients. Blood Purif. 24:508–516. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dusting GJ: Nitric oxide in coronary
artery disease: Roles in atherosclerosis, myocardial reperfusion
and heart failure. EXS. 76:33–55. 1996.PubMed/NCBI
|
|
17
|
Baptista J, Teles RC, da Silva PC, Pereira
H, Marques L, Santos R, Carvalho H, Martins D, Farto e Abreu P,
Araújo J, et al: Five-year clinical results of coronary angioplasty
with drug-eluting stents. National initiative in strategic
innovation, iNOS. Rev Port Cardiol. 29:243–251. 2010.(In English,
Portuguese). PubMed/NCBI
|
|
18
|
Meng QH, Irvine S, Tagalakis AD, McAnulty
RJ, McEwan JR and Hart SL: Inhibition of neointimal hyperplasia in
a rabbit vein graft model following non-viral transfection with
human iNOS cDNA. Gene Ther. 20:979–986. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wisel S, Khan M, Kuppusamy ML, Mohan IK,
Chacko SM, Rivera BK, Sun BC, Hideg K and Kuppusamy P:
Pharmacological preconditioning of mesenchymal stem cells with
trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects
hypoxic cells against oxidative stress and enhances recovery of
myocardial function in infarcted heart through Bcl-2 expression. J
Pharmacol Exp Ther. 329:543–550. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Zhang H, Chai F, Liu X and Berk M:
The effects of escitalopram on myocardial apoptosis and the
expression of Bax and Bcl-2 during myocardial ischemia/reperfusion
in a model of rats with depression. BMC Psychiatry. 14:3492014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roxburgh CS and McMillan DC: Therapeutics
targeting innate immune/inflammatory responses through the
interleukin-6/JAK/STAT signal transduction pathway in patients with
cancer. Transl Res. 167:61–66. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wen SH, Li Y, Li C, Xia ZQ, Liu WF, Zhang
XY, Lei WL, Huang WQ and Liu KX: Ischemic postconditioning during
reperfusion attenuates intestinal injury and mucosal cell apoptosis
by inhibiting JAK/STAT signaling activation. Shock. 38:411–419.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mo ZC, Xiao J, Liu XH, Hu YW, Li XX, Yi
GH, Wang Z, Tang YL, Liao DF and Tang CK: AOPPs inhibits
cholesterol efflux by down-regulating ABCA1 expression in a
JAK/STAT signaling pathway-dependent manner. J Atheroscler Thromb.
18:796–807. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu Y, Zhou J, Xu C, Lin H, Xiao J, Wang Z
and Yang B: JAK/STAT and PI3K/AKT pathways form a mutual
transactivation loop and afford resistance to oxidative
stress-induced apoptosis in cardiomyocytes. Cell Physiol Biochem.
21:305–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Negoro S, Kunisada K, Tone E, Funamoto M,
Oh H, Kishimoto T and Yamauchi-Takihara K: Activation of JAK/STAT
pathway transduces cytoprotective signal in rat acute myocardial
infarction. Cardiovasc Res. 47:797–805. 2000. View Article : Google Scholar : PubMed/NCBI
|
